<DOC>
	<DOCNO>NCT00551655</DOCNO>
	<brief_summary>Tenofovir ( TDF ) -containing regimen may associate decrease renal function HIV-infected patient concurrently treat boost PI 's and/or co-morbid condition include diabetes mellitus , hypertension , anemia , hepatitis B , hepatitis C .</brief_summary>
	<brief_title>Impact Drug Therapy Co-Morbidities Development Renal Impairment HIV-Infected Patients</brief_title>
	<detailed_description>COL109413 Phase IV retrospective database study involve review medical record approximately 850 HIV-infected patient treat single center ( Peabody Health Clinic , Dallas , Texas ) follow 4-year period ( 2003-2006 ) . Patients whose GFR decrease &gt; 25 % baseline ( BL ) identify disease treatment characteristic compare patient whose GFR change . GFR calculate MDRD Cockcroft-Gault method . The following information note : patient age , weight , gender , race/ethnicity , viral load , CD4 cell count , serum creatinine available laboratory data , start HAART therapy ( TDF - vs non-TDF-containing ) , change drug treatment , co-morbidities ( hypertension , diabetes mellitus , anemia , hepatitis C virus hepatitis B virus infection ) , drug treatment co-morbidities non-HIV-related illness , adherence prescription refill . The study endpoint : time treatment initiation-to-event ( GFR decrease &gt; 25 % BL ) analysis TDF-containing vs non-TDF-containing antiretroviral therapy ; number patient convert National Kidney Foundation-defined mild moderate renal impairment moderate severe renal impairment TDF vs non-TDF-treated patient ; effect co-morbidities concomitant medication time GFR decrease &gt; 25 % BL .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>HIV positive patient see 2003 2006 Fewer two laboratory result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Human Immunodeficiency Viruses</keyword>
	<keyword>Glomerular Filtration Rate</keyword>
	<keyword>Tenofovir</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>